Sphere Fluidics Cyto-Mine Chroma
Sphere Fluidics has launched Cyto-Mine Chroma, the second generation of its flagship Cyto-Mine platform. The platform uses picodroplet technology to encapsulate single cells, assess cellular function, and isolate target cells for downstream expansion or analysis. The new system will still enable the functional screening of millions of cells per hour, but will feature a four-color laser and detector system, offering a greater degree of multiplexing compared to the first-generation platform, which featured one laser. The company will simultaneously launch its first multiplexed assay kit, improving the throughput and precision of clone selection by analyzing single cells for viability, productivity, and target specificity in one step, Sphere said. The platform will launch in the first quarter of 2025, and the company is currently taking orders, a spokesperson said.
Children's Mercy Kansas City Kiddose PGx Test
Pediatric health organization Children's Mercy Kansas City has launched the Kiddose PGx test, making it the first pediatric hospital in Missouri to offer in-house pharmacogenetic testing, the organization said. Pharmacogenetic testing has been part of clinical decision making at Children's Mercy since 2014, it added, but tests previously were sent to external labs. By analyzing how a patient's genes affect responses to medications, Kiddose PGx aims to enhance medication efficacy, minimize potential side effects, and improve treatment outcomes in therapeutic areas such as cancer, organ transplantation, chronic illness, and developmental or behavioral disorders.
LGC Clinical Diagnostics Seraseq ctDNA Prostate Reference Materials
LGC Clinical Diagnostics has launched Seraseq ctDNA prostate reference materials. The Seraseq ctDNA Prostate Mix contains various mutation types including SNVs, indels, duplications, translocations, and copy number variants and comes as wild type or with 0.5 percent or 1 percent variant allele frequencies.
Genomenon Mastermind ACMG Secondary Findings Variants Update
Genomenon has added curated variants for American College of Medical Genetics and Genomics (ACMG) secondary findings genes to its Mastermind Professional Edition software platform. The update enables labs to interpret these variants in patient testing data such as data from exome or genome tests.
For more recently launched products and services, please visit the New Products page on our website.